🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Getinge makes $200 mln provision related to surgical mesh claims

Published 2018-10-14, 03:45 p/m
Getinge makes $200 mln provision related to surgical mesh claims
GETIBs
-

Oct 14 (Reuters) - Swedish medical technology group Getinge GETIb.ST said on Sunday it would book a 1.8 billion crown ($200.9 million) provision related to surgical mesh product liability claims filed in the United States and Canada against its Atrium business.

The provision will impact the third quarter's operating result, the company said in a statement. of surgical mesh products have faced hundreds of lawsuits in the United States in recent years. Patients are claiming damages for complications and injuries allegedly sustained after receiving the implants.

Getinge said the claims were being vigorously defended and there had been no adverse verdicts against Atrium Medical, which manufactures the implants and was acquired by Getinge in 2011.

Atrium Medical is evaluating the future of the surgical mesh business, the Swedish medical technology company said.

The company may book additional provisions in the future, and actual costs may be higher or lower than the provisions made, Getinge said.

Getinge had booked a 350 million crown provision in the first quarter of the year, related mainly to a fraud probe in Brazil, and has been hit this year by higher costs and unfavourable currency moves. = 8.9609 Swedish crowns)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.